Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicky Makker

Showing results (61-70 of 140) with videos related to

Pageof 14
Sort By:
Gynecologic Oncology|October 16, 2012
A prospective study of quality of life in patients undergoing pelvic exenteration: interim resultsYoussef A Rezk, Karen E Hurley, Jeanne Carter, et al.
Gynecologic Oncology|October 21, 2023
Isolated vaginal recurrence in women with stage I endometrial cancerEric Rios-Doria, Han T Cun, Olga T Filippova, et al.
JCO Precision Oncology|October 20, 2022
Germline <i>SMARCA4</i> Deletion as a Driver of Uterine Cancer: An Atypical PresentationAnastasia Navitski, Duaa H Al-Rawi, Vicky Makker, et al.
Gynecologic Oncology|March 2, 2022
Sentinel lymph node biopsy alone compared to systematic lymphadenectomy in patients with uterine carcinosarcomaWilliam A Zammarrelli, Michelle Greenman, Eric Rios-Doria, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancerNicolás Gómez-Banoy, Eduardo Ortiz, Caroline S Jiang, et al.
Gynecologic Oncology|March 27, 2016
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group studyAndrea P Myers, Virginia L Filiaci, Yuping Zhang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancerEric Rios-Doria, Nadeem R Abu-Rustum, Kaled M Alektiar, et al.
Cancer|July 6, 2022
Impact of obesity and white adipose tissue inflammation on the omental microenvironment in endometrial cancerLea A Moukarzel, Lorenzo Ferrando, Anthe Stylianou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 23, 2024
Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancerEric Rios-Doria, Nadeem R Abu-Rustum, Kaled M Alektiar, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Oncologic outcomes based on lymphovascular space invasion in node-negative FIGO 2009 stage I endometrioid endometrial adenocarcinoma: a multicenter retrospective cohort studyChristian Dagher, Pernille Bjerre Trent, Rofieda Alwaqfi, et al.
Pageof 14

Showing results (61-70 of 140) with videos related to

Sort By:
Pageof 14
Gynecologic Oncology|October 16, 2012
A prospective study of quality of life in patients undergoing pelvic exenteration: interim resultsYoussef A Rezk, Karen E Hurley, Jeanne Carter, et al.
Gynecologic Oncology|October 21, 2023
Isolated vaginal recurrence in women with stage I endometrial cancerEric Rios-Doria, Han T Cun, Olga T Filippova, et al.
JCO Precision Oncology|October 20, 2022
Germline <i>SMARCA4</i> Deletion as a Driver of Uterine Cancer: An Atypical PresentationAnastasia Navitski, Duaa H Al-Rawi, Vicky Makker, et al.
Gynecologic Oncology|March 2, 2022
Sentinel lymph node biopsy alone compared to systematic lymphadenectomy in patients with uterine carcinosarcomaWilliam A Zammarrelli, Michelle Greenman, Eric Rios-Doria, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancerNicolás Gómez-Banoy, Eduardo Ortiz, Caroline S Jiang, et al.
Gynecologic Oncology|March 27, 2016
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group studyAndrea P Myers, Virginia L Filiaci, Yuping Zhang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancerEric Rios-Doria, Nadeem R Abu-Rustum, Kaled M Alektiar, et al.
Cancer|July 6, 2022
Impact of obesity and white adipose tissue inflammation on the omental microenvironment in endometrial cancerLea A Moukarzel, Lorenzo Ferrando, Anthe Stylianou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 23, 2024
Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancerEric Rios-Doria, Nadeem R Abu-Rustum, Kaled M Alektiar, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Oncologic outcomes based on lymphovascular space invasion in node-negative FIGO 2009 stage I endometrioid endometrial adenocarcinoma: a multicenter retrospective cohort studyChristian Dagher, Pernille Bjerre Trent, Rofieda Alwaqfi, et al.
Pageof 14